Disease monitoring in inflammatory bowel disease

C-Reactive Protein, Fecal Calprotectin and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

(2015) Mahmoud H Mosli et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn’s Disease

(2015) Gilles Boschetti et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test

(2015) Shiho Takashima et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery

(2015) Emily K. Wright et al.   GASTROENTEROLOGY

Serial Fecal Calprotectin Measurements to Detect Endoscopic Recurrence in Postoperative Crohn’s Disease: Is Colonoscopic Surveillance No Longer Needed?

(2015) Alain M. Schoepfer et al.   GASTROENTEROLOGY

Biomarkers of Inflammation in Inflammatory Bowel Disease

(2015) Bruce E. Sands   GASTROENTEROLOGY

High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis

(2015) Margalida Calafat et al.   INFLAMMATORY BOWEL DISEASES

Disease Activity Assessment in IBD

(2015) James D. Falvey et al.   INFLAMMATORY BOWEL DISEASES

Impact of disease location on fecal calprotectin levels in Crohn’s disease

(2015) Krisztina B. Gecse et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

557 Silent Crohn's Disease: Elevated C Reactive Protein in Asymptomatic Patients and Risk of Subsequent Hospitalization

(2015) Eric J. Vargas et al.   GASTROENTEROLOGY

Fecal Calprotectin Concentrations in Healthy Children Aged 1-18 Months

(2015) Feng Li et al.   PLoS One

Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases

(2014) B. Pariente et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year

(2014) Luisa Guidi et al.   DIGESTIVE AND LIVER DISEASE

Biomarkers of Inflammatory Bowel Disease

(2014) Yi Fengming et al.   DISEASE MARKERS

Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?

(2014) Pauliina Molander et al.   Journal of Crohns & Colitis

Fecal calprotectin one year after ileocaecal resection for Crohn's disease — A comparison with findings at ileocolonoscopy

(2014) Anders Lasson et al.   Journal of Crohns & Colitis

A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease

(2014) Graham D. Naismith et al.   Journal of Crohns & Colitis

The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease

(2014) Kaija-Leena Kolho et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study

(2014) Anders Lasson et al.   United European Gastroenterology Journal

The clinical value of faecal calprotectin and lactoferrin measurement in postoperative Crohn’s disease

(2014) Takayuki Yamamoto   United European Gastroenterology Journal

A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease

(2013) G. D. Naismith et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors

(2013) Claudio Papi et al.   DIGESTIVE AND LIVER DISEASE

Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin

(2013) Taina Sipponen   DIGESTIVE DISEASES

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

(2013) Laurent Peyrin-Biroulet et al.   GUT

A New Rapid Quantitative Test for Fecal Calprotectin Predicts Endoscopic Activity in Ulcerative Colitis

(2013) Triana Lobatón et al.   INFLAMMATORY BOWEL DISEASES

Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes

(2013) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy

(2013) Martine De Vos et al.   INFLAMMATORY BOWEL DISEASES

Faecal calprotectin but not C-Reactive Protein (CRP) or Crohn's Disease Activity Index (CDAI) may predict post-operative endoscopic recurrence of Crohn’s Disease

(2013) Konstantinos Papamichael et al.   Journal of Crohns & Colitis

A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease

(2013) Triana Lobatón et al.   Journal of Crohns & Colitis

C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn’s disease

(2013) Toshifumi Hibi et al.   JOURNAL OF GASTROENTEROLOGY

Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care

(2013) Polychronis Pavlidis et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Fistulizing Crohn’s disease: Diagnosis and management

(2013) Krisztina Gecse et al.   United European Gastroenterology Journal

Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn’s disease after ileocolonic resection: A prospective pilot study

(2013) Takayuki Yamamoto et al.   United European Gastroenterology Journal

C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I

(2012) W. Reinisch et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Evaluation of Mucosal Healing of Ulcerative Colitis by a Quantitative Fecal Immunochemical Test

(2012) Asuka Nakarai et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis

(2012) Nina Aagaard Poulsen et al.   BMC GASTROENTEROLOGY

Fecal Calprotectin in Pediatric Inflammatory Bowel Disease: A Systematic Review

(2012) Ioannis D. Kostakis et al.   DIGESTIVE DISEASES AND SCIENCES

Limitations of Fecal Calprotectin At Diagnosis in Untreated Pediatric Crohnʼs Disease

(2012) Ron Shaoul et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

(2012) Pauliina Molander et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies

(2012) Ren Mao et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy

(2012) Taina Sipponen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease

(2012) Clas-Göran af Björkesten et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Utility of faecal calprotectin analysis in adult inflammatory bowel disease

(2012) Lyn A Smith   WORLD JOURNAL OF GASTROENTEROLOGY

Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits

(2012) S. J. Whitehead et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease

(2011) L. S. Kiss et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease

(2011) Matthias Jürgens et al.   Clinical Gastroenterology and Hepatology

Fecal immunochemical test and small bowel lesions detected on capsule endoscopy

(2011) Zohar Levi et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

(2011) Edouard Louis et al.   GASTROENTEROLOGY

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

(2011) M. De Vos et al.   Journal of Crohns & Colitis

Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease

(2010) Dario Sorrentino et al.   Clinical Gastroenterology and Hepatology

Fecal calprotectin is a predictive marker of relapse in Crohnʼs disease involving the colon: a prospective study

(2010) Lamia Kallel et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Peripheral blood MicroRNAs distinguish active ulcerative colitis and Crohnʼs disease

(2010) Feng Wu et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection

(2010) Miguel Regueiro et al.   INFLAMMATORY BOWEL DISEASES

Faecal calprotectin in children with clinically quiescent inflammatory bowel disease

(2010) Taina Sipponen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI

(2009) Alain M Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Management of Crohn's Disease in Adults

(2009) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease

(2009) C. A. Lamb et al.   BRITISH JOURNAL OF SURGERY

C-Reactive Protein and Disease Activity in Children with Crohn’s Disease

(2009) Samantha Tilakaratne et al.   DIGESTIVE DISEASES AND SCIENCES

Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

(2009) Konstantinos Karmiris et al.   GASTROENTEROLOGY

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease

(2009) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?

(2009) Valle García-Sánchez et al.   Journal of Crohns & Colitis

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment

(2009) Taina Sipponen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers

(2009) S. Joshi et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings

(2008) T. SIPPONEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?

(2008) Renata D'Incà et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease

(2008) Jennifer Jones et al.   Clinical Gastroenterology and Hepatology

Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial

(2008) Gert Van Assche et al.   GASTROENTEROLOGY

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

(2008) M Henriksen et al.   GUT

Predicting relapse in Crohn's disease: a biopsychosocial model

(2008) A Bitton et al.   GUT

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease

(2008) Dorota Walkiewicz et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease

(2008) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES